NexgenRX Inc. Cash Flow-to-Debt Ratio
NexgenRX Inc. cash flow-to-debt ratio. NexgenRX Inc. (NXG) has a Cash Flow-to-Debt Ratio of 0.03x as of September 2025, meaning its operating cash flow of CA$880.82K could theoretically repay 0% of its total liabilities (CA$30.91 Million) in one year. Check NexgenRX Inc. cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of NexgenRX Inc. (2013–2024)
Cash flow-to-debt ratio of NexgenRX Inc. from 2013 to 2024. Historical debt coverage capacity for NexgenRX Inc. across 12 annual periods. Check NXG capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
NexgenRX Inc. Cash Flow-to-Debt Ratio by Year (2013–2024)
NexgenRX Inc. cash flow-to-debt ratio by year from 2013 to 2024. Year-by-year debt coverage analysis for NexgenRX Inc.. For the full cash flow conversion analysis, see NexgenRX Inc. operating cash flow efficiency.
| Year | CF-to-Debt Ratio | Operating CF (CAD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.05x | CA$1.15 Million | CA$22.84 Million | ▼ -11.4% |
| 2023 | 0.06x | CA$1.28 Million | CA$22.48 Million | ▼ -10.0% |
| 2022 | 0.06x | CA$1.07 Million | CA$16.90 Million | ▼ -67.5% |
| 2021 | 0.19x | CA$3.82 Million | CA$19.72 Million | ▲ +44.2% |
| 2020 | 0.13x | CA$2.65 Million | CA$19.72 Million | ▲ +148.9% |
| 2019 | 0.05x | CA$1.05 Million | CA$19.35 Million | ▲ +271.1% |
| 2018 | -0.03x | CA$-507.38K | CA$16.07 Million | ▲ +5.4% |
| 2017 | -0.03x | CA$-257.35K | CA$7.71 Million | ▼ -150.5% |
| 2016 | 0.07x | CA$490.96K | CA$7.43 Million | ▲ +1357.2% |
| 2015 | -0.01x | CA$-34.94K | CA$6.64 Million | ▲ +98.9% |
| 2014 | -0.47x | CA$-558.18K | CA$1.18 Million | ▼ -183.8% |
| 2013 | 0.56x | CA$774.08K | CA$1.37 Million | — |